- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00981604
Single Incision Laparoscopic Surgery (SILS) Versus Laparoscopic Cholecystectomy (SILS)
Single Incision Versus Laparoscopic Cholecystectomy
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This will be a prospective, randomized clinical trial involving patients who present to the hospital with an indication for cholecystectomy. We will offer enrollment to several institutions provided they receive institutional approval.
This will be a definitive trial design. Based on our operative times with SILS compared with our recent experience in standard laparoscopy, a sample size of 60 patients will give us a power of 0.8 with an α of 0.05.
After the procedure, both groups will be managed in the same manner per routine care. They will be discharged when tolerating a regular diet and their pain is well-controlled on oral pain medication.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Missouri
-
Kansas City, Missouri, United States, 64108
- Children's Mercy Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Need for cholecystectomy
Exclusion Criteria:
- Need for cholangiogram
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: SILS Cholecystectomy
Single Incision Laparoscopic Cholecystectomy
|
Single Incision Laparoscopic Cholecystectomy
|
|
Active Comparator: Standard Laparoscopic Cholecystectomy
4 port laparoscopic cholecystectomy
|
4 port technique
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Operative Time
Time Frame: 1 day
|
1 day
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Operative complications
Time Frame: 2 weeks
|
2 weeks
|
|
length of hospitalization
Time Frame: 1 week
|
1 week
|
|
doses of analgesics
Time Frame: 1 week
|
1 week
|
|
hospital/operation charges
Time Frame: 1 week
|
1 week
|
|
surgeon perception of difficulty
Time Frame: 1 day
|
1 day
|
|
cosmetic scores
Time Frame: 6 months
|
6 months
|
Collaborators and Investigators
Investigators
- Principal Investigator: Daniel J Ostlie, MD, Children's Mercy Hospital Kansas City
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Digestive System Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Neurologic Manifestations
- Movement Disorders
- Pathological Conditions, Anatomical
- Gallbladder Diseases
- Biliary Tract Diseases
- Bile Duct Diseases
- Common Bile Duct Diseases
- Calculi
- Dyskinesias
- Gallstones
- Cholelithiasis
- Cholecystolithiasis
- Biliary Dyskinesia
Other Study ID Numbers
- 09 07 132
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.